You Searched


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Customers also bought
More About Tepentox 50mg Tablet
Tepentox 50mg Tablet is an Extended-Release (ER) oral tablet containing Tapentadol. Tapentadol is a centrally acting analgesic (pain reliever) with a unique dual mechanism of action, classifying it as an opioid.
Tapentadol works by:
The Extended-Release (ER) formulation means the drug is released slowly into the body over many hours. This is crucial for maintaining consistent pain relief and is indicated for the management of moderate to severe chronic pain in adults when a continuous, around-the-clock analgesic is needed for an extended period. Because of its opioid nature, it carries a risk of dependence and misuse, and its use is reserved for significant pain where non-opioid options are insufficient.
Tepentox 50mg Tablet delivers Tapentadol in a sustained fashion, ensuring a steady state of the drug in the bloodstream to provide 24-hour pain control with twice-daily dosing.
Tapentadol is distinguished from traditional opioids by its dual mechanism of action, which provides a synergistic effect on pain relief:
1. Mu-Opioid Receptor Agonism
By binding to the μ-opioid receptors, Tapentadol modifies the perception of pain by reducing the intensity of pain signals reaching the brain. This is a common and potent mechanism for all opioid analgesics.
2. Norepinephrine Reuptake Inhibition (NRI)
This non-opioid mechanism is crucial. By preventing the reabsorption (reuptake) of the neurotransmitter Norepinephrine in the spinal cord, Tapentadol effectively increases the amount of Norepinephrine available in the nervous system. Norepinephrine plays a key role in the descending pain modulation system, enhancing the body's natural ability to suppress pain signals, particularly in chronic, neuropathic (nerve) pain.
This combination allows Tapentadol to manage both nociceptive (standard) pain and neuropathic pain effectively, often with a potentially lower incidence of some typical opioid side effects like severe gastrointestinal issues, compared to equipotent doses of traditional opioids. The Extended-Release (ER) coating is vital to ensure the drug is not released all at once, which could lead to a dangerous overdose.
Tepentox 50mg Tablet (Tapentadol Extended-Release Tablet) is indicated for:
Used when the pain is severe enough to require continuous, around-the-clock opioid treatment for an extended period, and when alternative treatment options are inadequate.
Effective in managing chronic pain that has a neuropathic component (nerve pain), such as diabetic peripheral neuropathy.
Tapentadol offers several specific benefits due to its unique pharmacological profile:
Effectively manages both nociceptive and neuropathic pain due to its combined opioid and NRI properties.
The extended-release formulation provides consistent pain control for 12 hours, reducing the peaks and troughs in drug concentration often associated with immediate-release dosing.
Offers a level of pain relief appropriate for moderate to severe pain.
Studies suggest a potentially lower incidence of certain gastrointestinal side effects (like severe constipation) compared to traditional opioids.
Tapentadol carries side effects typical of opioids, alongside effects related to its NRI action.
Tepentox 50mg Tablet is an oral, extended-release tablet and must be taken exactly as prescribed by your doctor.
Prolonged use during pregnancy can cause neonatal opioid withdrawal syndrome, which may be life-threatening if not recognised and treated.
Tapentadol passes into breast milk and can cause serious adverse reactions, including severe sedation and respiratory depression, in a nursing infant.
Alcohol, especially in combination with the ER formulation, can lead to a dangerously rapid release of the drug, resulting in fatal overdose and severe CNS depression.
This medicine causes severe dizziness, drowsiness, and impaired mental and physical ability. Do not drive or operate machinery.
Do not use in patients with severe respiratory depression or severe bronchial asthma. Use with caution in those with COPD.
Tapentadol should not be used within 14 days of taking MAOIs (e.g., phenelzine, isocarboxazid) due to the risk of severe Serotonin Syndrome.
There are no known significant interactions between Tapentadol and most foods. The medication can be taken with or without food.
The standard starting dose for the extended-release formulation is 50mg twice daily (every 12 hours).
An overdose of Tapentadol is a medical emergency that can be fatal, especially if the extended-release mechanism is compromised (crushed tablet) or if taken with alcohol or other CNS depressants.
If you miss a dose of Tepentox 50mg Tablet Extended-Release:
https://www.healthdirect.gov.au/tapentadol
https://www.drugs.com/tapentadol.html
https://www.mayoclinic.org/drugs-supplements/tapentadol-oral-route/description/drg-20072580
Therapeutic Class
Analgesic (Pain Reliever)
Action Class
Mu-Opioid Receptor Agonist + Norepinephrine Reuptake Inhibitor (NRI)
Chemical Class
Centrally Acting Opioid Analgesic
Habit Forming
Yes (High potential for dependence and addiction)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Top Selling Medicines
Top Selling Devices
Flat ₹100 off on first app order | Use Code: APP100 |
Flat ₹100 off on first app order
USE CODE: APP100

Download Now